Tue. 14 May 2024, 6:27am ET
Benzinga
Earnings, Earnings Beats, News
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.41 per share which beat the analyst consensus estimate of $0.26 by 57.69 percent. This is a 278.26 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $25.377 million which beat the analyst consensus estimate of $18.876 million by 34.44 percent. This is a 1.41K percent increase over sales of $1.677 million the same period last year.